Related Experiment Video
Updated: Oct 2, 2026
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
[Different immune profiles according to the immunological and clinical progression in vertically HIV-infected
Salvador Resino1, M Luisa Abad, José M Bellón
1Servicio de Inmunología. Hospital General Universitario Gregorio Marañón. Madrid. Spain.
Insights
HIV-infected children on antiretroviral treatment (ART) show distinct immunologic profiles based on disease stage. Despite ART, differences in T-cell subsets and cytokine production persist, highlighting the impact of HIV progression on immune status.
Area of Science:
- Immunology
- Virology
- Pediatrics
Context:
- Human Immunodeficiency Virus (HIV) infection in children requires ongoing management with antiretroviral treatment (ART).
- Understanding the long-term immunologic consequences of HIV infection, even with treatment, is crucial for patient care.
- Assessing immune system recovery and persistent alterations in HIV-infected children is an active area of research.
Purpose:
- To evaluate and compare the immunologic profile differences in vertically HIV-infected children undergoing ART, categorized by disease stage (A1, B2, C3).
- To investigate variations in T-cell subsets, cell proliferation, and cytokine production among different HIV disease categories and healthy controls.
Summary:
- HIV-infected children on ART exhibited varied T-cell subset compositions (e.g., CD8+ CD45RA+ CD62L+, CD8+ CD45RO+) and cytokine production (e.g., TNF-alpha) compared to controls.
- Cell proliferation responses differed significantly between disease stages, with higher indexes in the less advanced A1 group.
- Advanced HIV stages (B2, C3) showed distinct patterns of T-cell activation and exhaustion markers (e.g., CD38, HLA-DR) compared to the A1 group and controls.
Impact:
- The findings underscore that ART does not fully normalize the immune system in all HIV-infected children, with persistent immunologic differences linked to disease stage.
- This research provides valuable insights for tailoring therapeutic strategies and monitoring immune reconstitution in pediatric HIV management.
- Understanding these immunologic disparities can inform prognosis and the development of novel immunomodulatory interventions for HIV-infected children.
Background:
Our goal was to evaluate immunologic profile differences of HIV-infected children on antiretroviral treatment (ART). PATIENTS AND METHODDS: We studied 23 HIV-vertically infected children: a) N-A1 group: 10 HIV-infected children in A1 category; b) N-B2 group: 6 HIV-infected children in B2 category, and c) N-C3 group: 7 HIV-infected children in C3 category. We also studied 13 healthy age-matched HIV-negative children as controls. Cell proliferation was evaluated by incorporation of [3H]-Thymidine. The cytokine production in culture was quantified using commercially available specific ELISA assays. T-cell subsets were determined by flow cytometry.
Results:
Stimulation indexes of PHA, PWM, and anti-CD3+ anti-CD28 in N-A1 group were higher than in N-C3 group. In unstimulated PBMC, TNF-alpha production of HIV-infected children was higher than the control group (p < 0.05). However, in stimulated PBMC, TNF-alpha production in N-B2 and N-C3 groups was lower than the control group (p < 0.05). In HIV-infected children, CD8+ CD45RA+ CD62L+ T-cells were significantly lower (p < 0.01) and CD8+ CD45RO+ T-cells were higher (p < 0.05) than the control group. Moreover, in NA-1 group, CD4+ CD45RA+ CD62L+ T-cells were higher, and CD4+ CD45RO+ and CD8+ CD45RO+ T-cells were lower, than in N-B2 and N-C3 groups (p < 0.05). On the other hand, CD45RO+, CD45RO+ CD38+, HLA-DR+, CD38+ HLA-DR+ and CD38+ CD4+ and CD8+ T-cells were higher in N-C3 group than the N-A1 and control groups, except for CD4+ CD38+ T-cells. Activated CD8+ T-cells in N-A1 group were higher than in control group (p < 0.01).
Conclusion:
Our data demonstrate that in spite of ART, there still remain important differences in the immunologic status of HIV-infected children depending on the HIV-infection stage.
Related Concept Videos
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
01:22Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:23Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
01:23Cells of the Adaptive Immune Response